CLOs on the Move

NeuroSigma, Inc.

www.neurosigma.com

 
NeuroSigma is a Los Angeles-based life sciences company established to develop TNS technologies with the potential to transform medical practice and patients' lives.  NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD).
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.neurosigma.com
  • 10960 Wilshire Boulevard Suite 1910
    Los Angeles, CA USA 90024
  • Phone: 310.479.3100

Executives

Name Title Contact Details

Similar Companies

St Vincent Infirmary Medical Center

St Vincent Infirmary Medical Center is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Martin-Deneen Associates Inc

Martin-Deneen Associates Inc is a Grass Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Health-E-Quip

Health-E-Quip is a Hutchinson, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SNBL Clinical Pharmacology Center

SNBL Clinical Pharmacology Center is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.